Clover Health Earnings Reports

Clover Health reported a 9% year-over-year increase in insurance revenue for Q4 2024, reaching $331 million. The company's GAAP Net loss from continuing operations improved to $21 million, and Adjusted EBITDA increased to a profit of $8 million. Full year 2024 Adjusted EBITDA was $70 million. The company is issuing full year 2025 guidance.

Clover Health reported strong third quarter 2024 financial results, with significant improvements in GAAP Net Loss and Adjusted EBITDA. The company delivered 9% total revenue growth year-to-date compared to the prior year period. Increased full-year 2024 guidance midpoint to target updated range of Adjusted EBITDA profitability of $55 million - $65 million.

Clover Health reported an 11% year-over-year increase in total revenue for Q2 2024. GAAP Net Income improved to $7.2 million, compared to a $28.9 million loss in Q2 2023. Adjusted EBITDA increased to $36.2 million, up from $9.9 million in the same period last year. The company has also increased its full-year 2024 guidance for Insurance Revenue to $1.35 billion - $1.375 billion and Adjusted EBITDA profitability to $50 million - $65 million.

Clover Health reported a strong start to 2024, exceeding expectations with total revenue of $346.9 million and a GAAP net loss from continuing operations of $23.2 million. The company achieved Adjusted EBITDA profitability of $6.8 million, and insurance revenue grew by 8% year-over-year to $341.7 million. Improved full-year 2024 guidance was issued, and a share repurchase program of up to $20 million was authorized.

Clover Health reported Q4 2023 revenue of $510.3 million and a net loss of $70.5 million. The company's full-year revenue was $2,033.7 million, with a net loss of $213.4 million. Adjusted EBITDA for Q4 improved to a loss of $19.1 million compared to the prior year, with a full-year loss of $44.7 million, significantly better than the previous year's $290.4 million loss. Insurance MCR improved to 82.4% in Q4 and 81.2% for the full year.

Clover Health reported Q3 2023 revenue of $482.1 million and a net loss of $41.5 million. The company's Insurance MCR improved to 78.5%, and Adjusted EBITDA significantly improved to a loss of $5.1 million compared to the prior year period loss of $55.5 million.

Clover Health reported revenue of $513.6 million and a net loss of $28.8 million. Adjusted EBITDA improved to a profit of $10.0 million, and insurance revenue grew by 17% compared to Q2'22.

Clover Health reported strong Q1 2023 results with insurance revenue growth of 14% year-over-year and significant improvements in both Insurance and Non-Insurance MCR. The company also improved its full year 2023 guidance for the Insurance segment and consolidated Clover Health.

Clover Health reported significantly improved Insurance MCR, strong Insurance revenue growth, and continued moderation of growth in SG&A for Q4 2022. The company's Insurance MCR improved to 92.4%, driven by continued favorability in underlying operational trends. Clover Health finished the year with $555.3 million in restricted and unrestricted cash, cash equivalents, and investments.

Clover Health reported strong third quarter results, driven by improved Insurance Medical Care Ratio (MCR). The company is prioritizing profitability and expects to improve both Insurance and Non-Insurance MCRs from 2022 levels. They finished the quarter with $783 million in cash, cash equivalents, and investments.

Clover Health's Q1 2022 results showed significant year-over-year revenue growth, driven by increases in both Insurance and Non-Insurance segments. The company is focused on balancing growth with MCR reduction and operational efficiencies to drive towards profitability. Total revenue was $874.4 million, compared to $200.3 million in Q1 2021. Lives under Clover Management grew to approximately 257,000 from approximately 66,000 year-over-year.

Clover Health's Q4 2021 total revenue was $432.0 million, a 160% increase year-over-year. The company is expecting significant growth in revenue and lives under management while at the same time believes it is driving operating efficiencies and improved MCRs.

Clover Health's total revenue reached $427.2 million, a 153% increase year-over-year, with Lives under Clover Management growing by 125%. The GAAP Medicare Advantage (MA) Medical Care Ratio (MCR) improved by 850 basis points compared to the prior quarter. The company provides preliminary 2022 MA guidance, including average MA Lives of 82,000 and an MA MCR in the range of 95% to 99%.

Clover Health's Q2 2021 revenue increased by 140% year-over-year to $412 million, driven by the launch of Direct Contracting. Lives under Clover Management nearly doubled to approximately 129,000. The Clover Assistant is on track to manage over $1 billion of annualized revenue.

Clover Health reported a record revenue of $200.3 million for the first quarter of 2021, driven by an increase in membership and the launch of Direct Contracting, which nearly doubled the lives under management to over 130,000. However, the company experienced an increased GAAP MCR of 107.6% due to elevated COVID-related costs, resulting in a net loss of $48.4 million.

Clover Health reported Q4 2020 financial results, with total revenue reaching $166.2 million and a GAAP MCR of 109.3%. The company experienced a net loss of $81.6 million and an adjusted EBITDA loss of $63.4 million. Membership was 58,056 as of December 31, 2020, and lives under Clover Assistant management surpassed 32,400.